Loading people...
Margarita Chavez is a Venture Partner at Wellington Partners and an independent advisor for early-stage biopharmaceutical companies. Previously, she served as Managing Director at AbbVie Ventures, where she led investments in more than a dozen biotech startups, including Morphic Therapeutics and Alector Therapeutics. Before her venture capital tenure, Chavez worked as a Director in Abbott’s Global Pharmaceutical Licensing and Acquisitions division, managing major transactions such as the acquisition of Solvay. She began her career as a corporate and securities attorney at Brobeck Phleger & Harrison in Silicon Valley after earning her bachelor's degree and Juris Doctor from Santa Clara University. Chavez currently holds board positions at Newron Pharmaceuticals and the Santa Clara University Board of Regents, leveraging over 25 years of dealmaking experience to guide healthcare investments and acquisitions across the United States and Europe.
Margarita Chavez holds the esteemed position of Managing Director at AbbVie Ventures, the corporate venture capital arm of the global biopharmaceutical company, AbbVie. In this critical role, Ms. Chavez is at the forefront of identifying, evaluating, and executing strategic investments in innovative companies that are shaping the future of healthcare. Her work is pivotal in extending AbbVie's reach into emerging technologies and therapeutic modalities, ensuring the company remains a leader in medical innovation.
AbbVie Ventures' investment strategy is deeply integrated with AbbVie's overarching mission to discover and deliver transformative medicines. As a Managing Director, Margarita Chavez focuses on opportunities across a broad spectrum of the life sciences, including novel therapeutics, platform technologies, medical devices, and digital health solutions. Her investment thesis typically targets companies developing solutions in areas relevant to AbbVie's key therapeutic franchises, such as immunology, oncology, neuroscience, eye care, and virology. This strategic alignment ensures that investments not only offer financial returns but also provide potential synergies with AbbVie's research and development pipeline and commercial interests. She is often involved in early to growth-stage funding rounds, seeking out disruptive technologies and promising scientific breakthroughs that have the potential to address significant unmet patient needs.
While specific details of individual investments are often proprietary, Margarita Chavez's contributions are integral to building AbbVie Ventures' robust portfolio of cutting-edge companies. Her expertise helps guide these portfolio companies through critical development stages, leveraging AbbVie's extensive industry knowledge and resources.
Margarita Chavez's career background likely reflects a strong foundation in both science and business, typical for a leader in biopharmaceutical venture capital. Professionals in her position often bring years of experience in corporate development, venture capital, scientific research, or strategic consulting within the pharmaceutical or biotechnology industries. This diverse expertise equips her with a unique perspective to assess complex scientific data, market potential, and strategic fit, making informed investment decisions that drive innovation and value. Her leadership at AbbVie Ventures underscores a commitment to fostering a vibrant ecosystem of innovation, ultimately aiming to bring life-changing therapies to patients worldwide. Through her strategic vision and deep industry acumen, Margarita Chavez plays a vital role in advancing the next generation of healthcare solutions.
Margarita Chavez is a Managing Director at AbbVie Ventures, the corporate venture capital arm of AbbVie. She is responsible for identifying and investing in innovative life sciences companies that align with AbbVie's strategic goals and therapeutic areas.
Margarita Chavez invests in a range of life sciences companies, including those focused on novel therapeutics, platform technologies, medical devices, and digital health solutions. Her investments are strategically aligned with AbbVie's key therapeutic areas such as immunology, oncology, neuroscience, and eye care.
Margarita Chavez works as a Managing Director at AbbVie Ventures, which is the venture capital division of the global biopharmaceutical company AbbVie.
